Search Results
Jan 27, 2026, 09:00 ET BYOMA ANNOUNCES NEW GLOBAL PRESIDENT AND CHIEF BRAND OFFICER
skincare portfolio, including Cetaphil, Differin, and Alastin. She led the reinvigoration of Cetaphil, the portfolio's $1B+ flagship brand, bringing HCP credibility and science to the forefront and activating its influencer ecosystem at scale, anchored in Cetaphil's roots in trust and medical recommendation.
More news about: BYOMA
Jan 23, 2026, 14:06 ET University of Phoenix releases Healthcare Programs Guide
Administration (MHA)Master of Health Administration (Competency-Based)Master of Health Administration and Health Care Compliance and Privacy (MHA/HCP)Master of Health Administration and Master of Business Administration (MHA/MBA)Master of Public Health with a concentration in Community
More news about: University of Phoenix
Jan 22, 2026, 08:01 ET PulsePoint Secures Exclusive EHR Programmatic Partnership with Flora Health, Enabling Scalable In-Workflow Engagement with HCPs
broader HCP media strategy.Transparency leading to trusted measurement: With clinical signal-based delivery, strict compliance and comprehensive reporting, PulsePoint's EHR placements drive both high relevance and measurable outcomes, supporting the next era of performance-based HCP campaigns.About
More news about: PulsePoint
Jan 20, 2026, 10:00 ET Eurofins Viracor Launches Assays for Pneumococcal Antibody Detection, Expanding Serotype Coverage to Support Immunocompromised Patient Care
January 5, 2026. Available from: https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/Douglas J, Davidson J, Church M, Nutt J, Morris P, Kleiboeker S. Development of a Luminex Multiplexed Bead Based
More news about: Viracor Eurofins
Jan 20, 2026, 09:00 ET Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
https://www.cardiovascular.abbott/us/en/hcp/products/electrophysiology/mapping-systems/ensite-x.htmlAbout AbbottAbbott is a global healthcare leader that helps people live more
More news about: Abbott
Jan 16, 2026, 06:02 ET Doceree Sets the Global Standard for Healthcare Marketing, Building the World's Largest Network of Specialist Medical Publishers
for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Our patented AI understands multiple layers of clinical, behavioral, and contextual signals to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every
More news about: Doceree
Jan 15, 2026, 08:30 ET Doceree Enters 2026 as the Only Truly Direct Point-of-Care Engagement Platform at Scale
Operating System for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Hence, our patented AI understands multiple layers of context to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just
More news about: Doceree
Jan 15, 2026, 07:04 ET Elevate Healthcare Marketing Appoints Industry Veteran Karen Beckert as Executive Vice President, Client Engagement and Customer Activation
Beckert led integrated global and U.S. campaigns for some of the world's most recognized healthcare companies, spearheaded multimillion-dollar digital, HCP, and patient initiatives, and managed large-scale brand planning and quarterly business review processes. She has directed the launch of multiple high-profile
More news about: Elevate Healthcare Marketing
Jan 15, 2026, 00:00 ET Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry
engagements with healthcare professional (HCP) audiences. Backed by real-world insights from Docquity's network of more than 500,000 verified doctors across Asia, Docquity Engage™ provides pharmaceutical brand and field teams with real-time visibility into HCP behaviors and preferences, supported
More news about: Docquity
Jan 14, 2026, 09:00 ET ODAIA and Pulse Health Partner to Help Pharma Convert More HCPs and Increase Prescription Volume
field teams, and reduced HCP access, pharma companies must maximize every HCP interaction. Most rely on consultant-created physician personas and rules-based channel sequences built on backwards-looking data, a highly manual, one-size-fits-all approach to marketing that lacks HCP behavioral data and any
More news about: ODAIA
Jan 14, 2026, 09:00 ET Silk Debuts New Plant-Based Protein Milk with 13g of Complete Protein
[email protected] 1 IRI L52W 11/26/20232 Danone HCP Tracker Survey, 2025
More news about: Danone USA
Jan 14, 2026, 08:00 ET Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences
AI agents across a wide range of real-world use cases — from rapidly distilling lengthy clinical or market research documents, to generating dynamic HCP personas and personalized engagement strategies, to powering natural-language analytics that explain drivers behind forecast shifts or market performance.
More news about: Lynx Analytics
Jan 14, 2026, 08:00 ET Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences
AI agents across a wide range of real-world use cases — from rapidly distilling lengthy clinical or market research documents, to generating dynamic HCP personas and personalized engagement strategies, to powering natural-language analytics that explain drivers behind forecast shifts or market performance.
More news about: Lynx Analytics
Jan 08, 2026, 10:52 ET Doceree Emerges as Healthcare Marketing's Most AI-Forward Technology Platform, Building Industry's First Operating System for the AI Era
taxonomy for unmatched message relevance across specialist medical publishersDataIQ — a unified HCP intelligence platform that simplifies the understanding and activation of HCP audiences at scaleAdManager — Healthcare exclusive ad management platform to maximize inventory
More news about: Doceree
Jan 07, 2026, 15:00 ET Vi Releases 2026 State of AI Reports, Defining the New Performance Standard for Healthcare, Biopharma, and Wellness
operating layer across commercial, medical, and clinical functions. Organizations deploying multi-agent orchestration see 10–35% improvements in HCP activation, 2–3× faster evidence synthesis, 15–30% adherence lift, and 10–20% reductions in enrollment delays. AI-native trials,
More news about: Vi Labs
Jan 07, 2026, 08:15 ET PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma
the commercial function:3x average script lift.A 22% increase in brand strategy adherence.An 80% increase in HCP engagement rates.20-30% budget savings over traditional media buying models.Derek Choy, PharmaForceIQ Head of Product and former
More news about: PharmaForceIQ
Dec 23, 2025, 09:21 ET Patients Turn to AI for Health Research but Remain Cautious of Accuracy and Privacy Risks
dilute the quality of individualized care from their human HCPs. This suggests that the most successful AI tools will be those that enhance the patient-HCP relationship, not try to circumvent it."Health Union remains committed to bridging the gap between emerging technology and the fundamental need
More news about: Health Union
Dec 22, 2025, 09:30 ET Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints
clinical and regulatory frameworks. Credibility, not speed alone, is now the currency of influence in HCP engagement.Imperative 2: Deliver Context-First Engagement Across TouchpointsHCP engagement has shifted from linear learning to adaptive, moment-driven interactions across research,
More news about: Doceree
Dec 22, 2025, 09:00 ET Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
https://www.cardiovascular.abbott/us/en/hcp/products/electrophysiology/mapping-systems/ensite-x.htmlAbout AbbottAbbott is a global healthcare leader that helps people live more
More news about: Abbott
Dec 12, 2025, 11:45 ET Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer
Prescribing Information for Inluriyo. IN HCP ISI M APPAbout Verzenio (abemaciclib) Verzenio (abemaciclib) is approved to treat people with certain HR+, HER2-
More news about: Eli Lilly and Company
Dec 11, 2025, 16:55 ET Experienced Yale Quarterback Brogan McCaughey Enters NCAA Transfer Portal with Two Years of Eligibility Remaining
https://x.com/BroganMccaughey/status/1998854685621629416/video/2]Brogan McCaughey is being represented by HCP & Associates. For all media inquires please contact the number below.Media Contact:Sean ConiglioSenior Communications
More news about: HCP & Associates, Inc.
Dec 11, 2025, 08:00 ET ZS to introduce ZAIDYN® intelligence into Agentforce Life Sciences
This ZAIDYN integration empowers organizations on three core fronts:Personalized, compliant healthcare professional (HCP) engagement: Rich healthcare professional intelligence, derived from
More news about: ZS
Dec 10, 2025, 11:28 ET CXZONE VON ACTO ERHÄLT ZWEI AUSZEICHNUNGEN BEI DEN 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS
„klinischen IQ" und ihrer „Kommunikation". CxZone basiert auf der von ACTO entwickelten Empathetic AI-Engine, die die KI-simulierte Interaktion mit HCP realistisch und persönlich macht.Traditionelle Rollenspielübungen können sowohl für die Teilnehmer als auch für die Moderatoren unangenehm und
More news about: ACTO Technologies, Inc.
Dec 09, 2025, 08:30 ET ACTO'S CXZONE WINS DUAL HONORS IN THE 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS
what matters most in HCP conversations—allowing field teams to work on clinical fluency and product messaging, along with receiving specific "Clinical IQ" and "Messaging" scores and feedback. CxZone is built on ACTO's proprietary Empathetic AI engine, making the AI-simulated HCP interaction realistic
More news about: ACTO Technologies, Inc.
Dec 09, 2025, 08:30 ET ACTO'S CXZONE WINS DUAL HONORS IN THE 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS
what matters most in HCP conversations—allowing field teams to work on clinical fluency and product messaging, along with receiving specific "Clinical IQ" and "Messaging" scores and feedback. CxZone is built on ACTO's proprietary Empathetic AI engine, making the AI-simulated HCP interaction realistic
More news about: ACTO Technologies, Inc.